Logo image of MCAC

MONTEREY CAPITAL ACQUISITI-A (MCAC) Stock Fundamental Analysis

NASDAQ:MCAC - Nasdaq - US61244M1099 - Common Stock - Currency: USD

3.54  -3.47 (-49.5%)

After market: 3.09 -0.45 (-12.71%)

Fundamental Rating

0

MCAC gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. Both the profitability and financial health of MCAC have multiple concerns. MCAC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MCAC has reported negative net income.
MCAC had a negative operating cash flow in the past year.
MCAC Yearly Net Income VS EBIT VS OCF VS FCFMCAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2021 2022 2023 -5M -10M

1.2 Ratios

Industry RankSector Rank
ROA -29.72%
ROE -59.72%
ROIC N/A
ROA(3y)-9.67%
ROA(5y)N/A
ROE(3y)-78.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MCAC Yearly ROA, ROE, ROICMCAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2021 2022 2023 0 50 -50 -100 -150

1.3 Margins

MCAC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MCAC Yearly Profit, Operating, Gross MarginsMCAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2021 2022 2023

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for MCAC remains at a similar level compared to 1 year ago.
MCAC has a worse debt/assets ratio than last year.
MCAC Yearly Shares OutstandingMCAC Yearly Shares OutstandingYearly Shares Outstanding 2019 2021 2022 2023 2M 4M 6M
MCAC Yearly Total Debt VS Total AssetsMCAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

MCAC has an Altman-Z score of 0.34. This is a bad value and indicates that MCAC is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 0.04 indicates that MCAC is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 0.34
ROIC/WACCN/A
WACCN/A
MCAC Yearly LT Debt VS Equity VS FCFMCAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

MCAC has a Current Ratio of 0.00. This is a bad value and indicates that MCAC is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.00 indicates that MCAC may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0
Quick Ratio 0
MCAC Yearly Current Assets VS Current LiabilitesMCAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2021 2022 2023 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

MCAC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -355.80%.
EPS 1Y (TTM)-355.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1890.74%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MCAC Yearly Revenue VS EstimatesMCAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2021 2022 2023
MCAC Yearly EPS VS EstimatesMCAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MCAC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MCAC Price Earnings VS Forward Price EarningsMCAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MCAC Per share dataMCAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MCAC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONTEREY CAPITAL ACQUISITI-A

NASDAQ:MCAC (7/12/2024, 8:00:01 PM)

After market: 3.09 -0.45 (-12.71%)

3.54

-3.47 (-49.5%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-14 2022-11-14
Earnings (Next)02-27 2023-02-27
Inst Owners14.75%
Inst Owner Change-24.17%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap87.76M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.18
P/tB 2.18
EV/EBITDA N/A
EPS(TTM)-2.28
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0
BVpS1.62
TBVpS1.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -29.72%
ROE -59.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-9.67%
ROA(5y)N/A
ROE(3y)-78.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0
Quick Ratio 0
Altman-Z 0.34
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-355.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1890.74%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-294.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-294.54%
OCF growth 3YN/A
OCF growth 5YN/A